Researchers conduct a SARS-CoV-2 serosurvey of blood donors in New Zealand
Researchers conduct a SARS-CoV-2 serosurvey of blood donors in New Zealand Various strategies are being deployed across the globe to curb the ongoing coronavirus disease 2019 (COVID-19) pandemic. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the novel causal agent of the COVID-19. This virus is highly contagious and is transmitted via primarily via respiratory droplets from infected individuals. The approaches undertaken by New Zealand have been reported to have effectively reduced the incidence of COVID-19. In New Zealand, the first COVID-19 infection was reported on Februa...